Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients

Multiple myeloma (MM) is associated with an increased risk of venous thrombosis (VTE). In the United Kingdom Medical Research Council (MRC) XI study of patients treated with immunomodulatory therapy, the VTE rate was 11.8% despite 87.7% of the patients being on thromboprophylaxis at the time of thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, Aisling, Quinn, John, Lavin, Michelle, Thornton, Patrick, O’Donnell, James, Murphy, Philip, Glavey, Siobhán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396929/
https://www.ncbi.nlm.nih.gov/pubmed/34441832
http://dx.doi.org/10.3390/jcm10163536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396929/
https://www.ncbi.nlm.nih.gov/pubmed/34441832
http://dx.doi.org/10.3390/jcm10163536

Ejemplares similares